The Weekly Roundup: July 28-August 1

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Three Building Blocks of a Young Dermatologist’s Financial Foundation

Young dermatologists should learn essential financial planning strategies to secure their future, including saving early, securing insurance, and budgeting effectively.

Is AI Transforming Skin Care?

AI revolutionizes skin care by personalizing product recommendations, enhancing customer satisfaction, and transforming dermatologist-patient interactions for better outcomes.

Dermatology Times July 2025 Print Recap

Learn more about the in-depth topics covered in the July 2025 print issue of Dermatology Times.

Interview Intersection: Expert Interviews From July 2025

Dermatology Times is recapping our exclusive expert interviews from the month of July.

Dermatology Times July 2025 Recap

Dermatology Times is looking back on the top stories in dermatology from the month of July.

J&J Files sBLA for Guselkumab Structural Damage Data

Johnson & Johnson seeks FDA approval to update guselkumab's label, highlighting its unique ability to significantly inhibit joint damage in active psoriatic arthritis.

FDA Grants Fast Track Designation to Nektar's Rezpegaldesleukin in Alopecia Areata

Nektar Therapeutics advances alopecia areata treatment with FDA's Fast Track designation for rezpegaldesleukin, targeting immune modulation in chronic hair loss.

Improving Diagnoses and Trust in Patients With Skin of Color

At Elevate-Derm Summer, Buchi Neita, MCMSc, PA-C, discussed enhancing dermatologic care for patients with skin of color by recognizing characteristics in common conditions and offered strategies to build rapport with patients.

Top 5 Articles of the Month: July

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

Three A’s Framework Offers Practical SDOH Solutions

Coates addresses social determinants of health in pediatric dermatology, emphasizing their impact on treatment and patient outcomes.

Unraveling Complex Dermatology, Challenging Diagnoses, and the Power of Visuals

Lauren Madigan, MD, shares vital insights on complex dermatology, emphasizing accurate diagnoses and the importance of diversity in dermatologic imagery.

Journal Digest: July 30, 2025

This review of the latest dermatologic studies includes insights into emerging terbinafine-resistant trichophyton dermatophytosis, clinicodemographic features and usage of oral immunosuppressive agents in childhood and adolescent vitiligo, and more.

LEO Pharma’s Robert Spurr on Delgocitinib Cream’s Approval and the Future of Chronic Hand Eczema

Delgocitinib cream recently became the first FDA-approved treatment for chronic hand eczema. Robert Spurr of LEO Pharma shares insights into what it means for providers and patients.

New Phase 3 UP-AA Data Demonstrate Significant Improvement in SALT Score With Upadacitinib in Alopecia

AbbVie's upadacitinib showed promising results in treating severe alopecia areata, achieving significant hair regrowth in pivotal phase 3 trials.

Derm Dispatch: Navigating Industry, Health Care, and Career Transitions as a PA

Explore career transitions in healthcare as PAs Renata Block, MMS, PA-C, and Jessica Dell'Aquila, MS, PA-C, share insights on professional growth and evolving roles in dermatology.

Phase 2b Repibresib Study Falls Short of Key Goals

VYNE Therapeutics reveals disappointing phase 2b trial results for repibresib gel in nonsegmental vitiligo, missing key efficacy endpoints.

New Research Reveals PC111's Potential to Revolutionize Pemphigus and SJS/TEN Treatment

PC111, a novel therapy from Scinai, targets pemphigus vulgaris and SJS/TEN, offering rapid relief without immunosuppression.

SPD 2025: Bridging Research and Clinical Care

Deepti Gupta, MD, emphasized SPD's focus on delivering practical clinical insights, highlighting emerging research, and fostering meaningful professional connections.

Clinical Community Forms Around Shared AD Challenges

At a recent Dermatology Times Case-Based Roundtable, attendees discussed several challenging AD cases.

Soligenix Reports Positive Phase 2a Data in Behçet’s Disease

The open-label trial showed dusquetide produced similar results to apremilast in reducing oral ulcers, pain, and ulcer duration.

Liza O’Dowd, MD, Discusses What Sets Icotrokinra Apart in Psoriasis Treatment Following NDA Submission

O'Dowd discusses J&J's recent NDA submission for icotrokinra in psoriasis.

How One Dermatologist is Revolutionizing Sun Care to Protect a New Generation

Whitney Hovenic, MD, highlights alarming trends in Gen Z's sun protection habits and introduces SPOOGE, a new sunscreen brand promoting skin health.

Q&A with Jesse Lewin, MD, FACMS: Celebrating 10 Years of Innovations in Skin Cancer at Mount Sinai

Discover how the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center at Mount Sinai leads in innovative skin cancer care and research, celebrating a decade of excellence.

BMS Pursues Global Approval for Deucravacitinib for PsA

Deucravacitinib-treated patients achieved superior clinical responses compared to placebo at week 16 in both trials.

Derm Dispatch: Adam Friedman, MD, FAAD, Unpacks the Science Behind CBD’s Role in UV Protection

Renata Block, DMSc, MMS, PA-C, interviews Adam Friedman, MD, FAAD, about his research into cannabidiol’s photoprotective potential, clinical trial design, and future directions.

Dermatology Conferences and Meetings Calendar: August 2025

Dermatology Times has compiled a list of dermatological meetings taking place during the month of August.

Sculptra and Restylane Deliver 9-Month Skin, Confidence Boost Post-Medication Weight Loss

Michael Somenek, MD, shares how a first-of-its-kind Galderma trial using Sculptra and Restylane helped restore volume and skin quality in patients on GLP-1 medications.

Patterns of Cutaneous Reactions to Nemolizumab in AD

The study found no association between cutaneous events and baseline EASI scores, eosinophil counts, or IgE levels.

Leveraging Topicals to Address Severe Itch in Pediatric Atopic Dermatitis

In a discussion on pediatric AD management, Shanna Miranti, MPAS, PA-C, emphasized the enduring role of topical treatments for residual itch and flares, and highlighted the importance of rapid-acting agents such as ruxolitinib cream.

SPOOGE by Whitney Hovenic, MD, Aims to Bridge the Sunscreen Adherence Gap in a Unique Way

Whitney Hovenic, MD's new SPOOGE sunscreen hopes to engage Gen Z in sun protection, merging skincare with fun and effective sun care strategies.

Common Sunscreen Allergens: What to Watch For

Glenn Kolansky, MD, FAAD, identifies oxybenzone and fragrances as leading causes of sunscreen allergies.

The Latest Trends in Laser and Energy-Based Dermatology

Dendy Engelman, MD, FACMS, FAAD, explores the latest advancements in laser and energy-based dermatological treatments, including skin resurfacing and body contouring.